FIM
DNLI icon

Fernwood Investment Management’s Denali Therapeutics DNLI Stock Holding History

Fernwood Investment Management’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,000
Closed -$103K – 317
2024
Q1 		$103K Buy
+5,000
New +$94K 0.03% 261
2021
Q3 		– Sell
-3,000
Closed -$235K – 199
2021
Q2 		$235K Buy
+3,000
New +$186K 0.08% 178
2021
Q1 		– Sell
-3,000
Closed -$251K – 194
2020
Q4 		$251K Buy
+3,000
New +$181K 0.1% 160

Other funds holding DNLI

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fernwood Investment Management's DNLI Position: Q2 2024 in Review

Fernwood Investment Management sold out of Denali Therapeutics (DNLI) in Q2 2024, closing a stake of 5,000 shares — an estimated $103K sold.

Fernwood Investment Management first reported a position in DNLI in Q4 2020 and held it in 3 quarters. The position peaked at $251K in Q4 2020. 203 funds tracked by Wall St. Rank hold DNLI as of Q2 2024.

  • Fernwood Investment Management reported no remaining Denali Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Fernwood Investment Management sold 5,000 Denali Therapeutics shares in Q2 2024, an estimated $103K.
  • Fernwood Investment Management first reported a position in Denali Therapeutics in Q4 2020 and held it in 3 quarters.
  • Fernwood Investment Management's Denali Therapeutics position peaked at $251K in Q4 2020.
  • 203 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2024.

Based on Fernwood Investment Management's 13F filing for Q2 2024, filed 31 Jul 2024.